作者: Faizan Malik , Naveed Ali , Syed Imran Mustafa Jafri , Ali Ghani , Mohsin Hamid
DOI: 10.1186/S13256-017-1278-3
关键词:
摘要: Background We present the first full case report of treatment mast cell activation syndrome with continuous diphenhydramine infusion, which resulted in improvement anaphylactic reactions and a decrease hospital readmission. Furthermore, patient received imatinib absence KIT-D816V mutation, led to further quality life. Currently, we are trying wean this off diphenhydramine; if successful, attempt will represent reported case.